Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
Dipayan Chaudhuri, Kiyoka Sasaki, Aram Karkar, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 5, pp. 521-537
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Christian Zanza, Tatsiana Romenskaya, A Manetti, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 144-144
Open Access | Times Cited: 240
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 199
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management
Ellen Gorman, Cecilia M. O’Kane, Daniel F. McAuley
The Lancet (2022) Vol. 400, Iss. 10358, pp. 1157-1170
Open Access | Times Cited: 198
Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin, et al.
Pneumonia (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 110
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline
Nida Qadir, Sarina K. Sahetya, Laveena Munshi, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 1, pp. 24-36
Open Access | Times Cited: 106
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2023) Vol. 401, Iss. 10387, pp. 1499-1507
Open Access | Times Cited: 82
2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia
Dipayan Chaudhuri, Andrea M. Nei, Bram Rochwerg, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 5, pp. e219-e233
Open Access | Times Cited: 45
Acute Respiratory Distress Syndrome
Thomas Staudinger
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2025)
Closed Access | Times Cited: 8
The relationship between steroid treatment and mortality in patients with COVID-19 followed up in an intensive care unit
Huseyin Ali Ozturk, Fatih Necip Arıcı
PeerJ (2025) Vol. 13, pp. e18606-e18606
Open Access | Times Cited: 1
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia
Naveed Saleem, Adarsh Kulkarni, Timothy Arthur Chandos Snow, et al.
CHEST Journal (2022) Vol. 163, Iss. 3, pp. 484-497
Open Access | Times Cited: 61
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, et al.
Journal of Intensive Care Medicine (2021) Vol. 37, Iss. 4, pp. 491-499
Open Access | Times Cited: 60
COVID-19 and corticosteroids: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1189-1205
Open Access | Times Cited: 59
Use of steroids in COVID-19 patients: A meta-analysis
Manisha Thakur, Ashok Kumar Datusalia, Anoop Kumar
European Journal of Pharmacology (2021) Vol. 914, pp. 174579-174579
Open Access | Times Cited: 55
Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis
Ryan Ruiyang Ling, Kollengode Ramanathan, Jackie Jia Lin Sim, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 50
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 47
Guideline-based management of acute respiratory failure and acute respiratory distress syndrome
Seitaro Fujishima
Journal of Intensive Care (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis
Tyler Pitre, Daniyal Abdali, Dipayan Chaudhuri, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. 11, pp. 2593-2606
Open Access | Times Cited: 30
Acute Respiratory Distress Syndrome; A Review of Recent Updates and a Glance into the Future
Husayn F. Ramji, Maida Hafiz, Hiba Hammad Altaq, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1528-1528
Open Access | Times Cited: 24
Corticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis
Tyler Pitre, Katherine Drover, Dipayan Chaudhuri, et al.
Critical Care Explorations (2024) Vol. 6, Iss. 1, pp. e1000-e1000
Open Access | Times Cited: 12
Improving management of ARDS: uniting acute management and long-term recovery
Nicola Latronico, Matthias Eikermann, E. Wesley Ely, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Acute respiratory distress syndrome
Katherine D. Wick, Lorraine B. Ware, Michael A. Matthay
BMJ (2024), pp. e076612-e076612
Closed Access | Times Cited: 7
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов, А. М. Лила, Mazurov Vi, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 239-254
Open Access | Times Cited: 50
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
Luis Felipe Reyes, Alejandro Rodríguez, Alirio Bastidas, et al.
Journal of Critical Care (2022) Vol. 69, pp. 154014-154014
Open Access | Times Cited: 31
Dexamethasone for Inpatients With COVID-19 in a National Cohort
Ahmad Mourad, Dylan Thibault, Thomas L Holland, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238516-e238516
Open Access | Times Cited: 19
Efficacy and safety of corticosteroids in cardiac arrest: a systematic review, meta-analysis and trial sequential analysis of randomized control trials
J.B. Penn, Will Douglas, Jeffrey Curran, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top